The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 367.50
Bid: 366.50
Ask: 367.50
Change: 3.00 (0.82%)
Spread: 1.00 (0.273%)
Open: 358.00
High: 369.50
Low: 358.00
Prev. Close: 364.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing in Breedon Group plc

6 Nov 2019 07:00

RNS Number : 3937S
J.P. Morgan Securities PLC.
06 November 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OR THE SOLICITATION OF AN OFFER TO BUY IN ANY JURISDICTION, NOR SHALL THERE BE ANY SALE, OF THE SECURITIES REFERRED TO HEREIN IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SALES WOULD BE PROHIBITED BY APPLICABLE LAW.

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

Result of placing of ordinary shares in Breedon Group plc ("Breedon" or the "Company")

6 November 2019

Further to the announcement released on 5 November 2019, M1 Cement Holding Limited ("M1" or the "Seller") announce that pursuant to the Placing, the Seller has sold (subject to completion of the Placing) an aggregate of 139.7 million ordinary shares in the share capital of Breedon, by way of an accelerated bookbuild to institutional investors at a price of 59 pence per ordinary share, raising gross proceeds of £82.4 million.

Following the completion of the Placing, the Seller will no longer own any shares in the Company.

Allocations will be confirmed today, 6 November, for settlement on 8 November.

J.P. Morgan Securities plc which conducts its UK investment banking activities as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), acted as Sole Bookrunner in connection with the Placing.

No proceeds from the Placing will be received by Breedon.

Enquiries

 

J.P. Morgan +44 (0) 20 7742 4000

Sjoerd Leenart

Milena Grayde

Barry Meyers

 

IMPORTANT NOTICE

This announcement is not for publication or distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States and the District of Columbia), Canada, Australia, South Africa, Japan or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. No action has been taken that would permit an offering of the Placing Shares or possession or distribution of this announcement in any jurisdiction where action for that purpose is required.

This announcement does not constitute or form part of an offer for sale or solicitation of an offer to purchase or subscribe for securities in the United States, Canada, Australia, South Africa, Japan or any other jurisdiction and the securities referred to herein have not been registered under the securities laws of any such jurisdiction. The Placing Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold, directly or indirectly, in the United States, absent registration under or an exemption from, or transaction not subject to, the registration requirements of, the Securities Act. No public offering of securities is being made in the United States or in any other jurisdiction.

In member states of the European Economic Area ("EEA"), this announcement and any offer of Placing Shares if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Regulation ("Qualified Investors"). For these purposes, the expression "Prospectus Regulation" means Regulation (EU) 2017/1129. In the United Kingdom this announcement is only being distributed to, and is only directed at, and any investment or investment activity to which this announcement relates is available only to, and will be engaged in only with, Qualified Investors who are (i) investment professionals falling with Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order"); or (ii) high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) other persons to whom an offer of the Placing Shares may otherwise be lawfully communicated (all such persons together being referred to as "relevant persons"). Persons who are not relevant persons should not take any action on the basis of this announcement and should not act or rely on it.

No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision in connection with the Placing must be made on the basis of all publicly available information relating to Breedon and its shares. Such information has not been independently verified and the Seller and the Sole Bookrunner are not responsible, and expressly disclaim any liability, for such information. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness.

In connection with the Placing, the Sole Bookrunner or any of their respective affiliates may take up a portion of the Placing Shares as a principal position and in that capacity may retain, purchase, sell or offer to sell for its own account such Placing Shares and other securities of Breedon or related investments in connection with the Placing or otherwise. Accordingly, references to the Placing Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by the Sole Bookrunner and any of its respective affiliates acting as investors for their own accounts. The Sole Bookrunner does not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

This announcement does not purport to identify or suggest the risks (direct or indirect) which may be associated with an investment in Breedon or its shares.

This announcement does not constitute a recommendation concerning the Placing. The price and value of securities and any income from them can go down as well as up. Past performance is not a guide to future performance. Acquiring Placing Shares to which this announcement relates may expose an investor to a significant risk of losing all of the amount invested. Potential investors should consult a professional advisor as to the suitability of the Placing for the entity or person concerned. This announcement does not represent the announcement of a definitive agreement to proceed with the Placing and, accordingly, there can be no certainty that the Placing will proceed. The Seller reserve the right not to proceed with the Placing or to vary the terms of the offering in any way.

 

J.P. Morgan Cazenove is authorised by the Prudential Regulatory Authority ("PRA") and regulated by the Financial Conduct Authority ("FCA") and the PRA. J.P. Morgan Cazenove is acting for the Seller only in connection with the Placing and no one else, and will not be responsible to anyone other than the Seller for providing the protections offered to clients nor for providing advice in relation to the Placing Shares or the Placing, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Certain figures contained in this announcement, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this announcement may not conform exactly with the total figure given.

This announcement includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and include statements regarding intentions, beliefs or current expectations. No assurances can be given that the forward-looking statements in this announcement will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIUGGGAGUPBPGA
Date   Source Headline
1st Jun 20226:05 pmRNSStandard form for notification of major holdings
1st Jun 20224:27 pmRNSStandard form for notification of major holdings
24th May 20222:13 pmRNSPDMR Dealings
16th May 20223:26 pmRNSStandard form for notification of major holdings
10th May 202210:20 amRNSHolding(s) in Company
3rd May 20224:03 pmRNSDirector/PDMR Shareholding
29th Apr 202212:28 pmRNSHolding(s) in Company
28th Apr 20223:52 pmRNSResult of AGM
28th Apr 20227:00 amRNSAGM Trading update
25th Apr 20221:22 pmRNSStandard form for notification of major holdings
20th Apr 20228:31 amRNSDirector/PDMR Shareholding
14th Apr 20223:04 pmRNSStandard form for notification of major holdings
13th Apr 20229:24 amRNSStandard form for notification of major holdings
12th Apr 20227:00 amRNSDirector/PDMR Shareholding
11th Apr 20222:49 pmRNSStandard form for notification of major holdings
11th Apr 20222:44 pmRNSStandard form for notification of major holdings
5th Apr 20223:30 pmRNSGrant of SAYE Options and PDMR Dealings
31st Mar 202212:07 pmRNSTotal Voting Rights
24th Mar 20223:09 pmRNSHolding(s) in Company
21st Mar 202210:06 amRNS2021 Report and Notice of Annual General Meeting
9th Mar 20227:00 amRNSFinal Results
28th Feb 20224:22 pmRNSTotal Voting Rights
14th Feb 20229:36 amRNSHolding(s) in Company
11th Feb 20223:40 pmRNSNotice of Annual Results 2021
3rd Feb 20225:29 pmRNSPDMR Dealings
31st Jan 20229:53 amRNSTotal Voting Rights
7th Jan 20224:32 pmRNSBlocklisting Update
2nd Dec 20213:47 pmRNSPDMR Dealings
30th Nov 202111:00 amRNSTotal Voting Rights
24th Nov 20212:00 pmRNSDelivering the next chapter of growth
24th Nov 20217:00 amRNSTrading Update November 2021
4th Nov 20213:55 pmRNSNotice of Trading Update and Capital Markets Event
29th Oct 20218:48 amRNSTotal Voting Rights
12th Oct 202112:39 pmRNSHolding(s) in Company
6th Oct 20212:47 pmRNSHolding(s) in Company
29th Sep 20212:54 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSHolding(s) in Company
15th Sep 20213:56 pmRNSHolding(s) in Company
14th Sep 20216:00 pmRNSDirector/PDMR Shareholding
13th Sep 20219:35 amRNSHolding(s) in Company
27th Aug 20219:00 amRNSTotal Voting Rights
30th Jul 202110:36 amRNSHolding(s) in Company
30th Jul 20218:52 amRNSTotal Voting Rights
22nd Jul 20217:01 amRNS2021 Interim Results
22nd Jul 20217:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
19th Jul 20219:07 amRNSTR-1: Notification of major holdings
7th Jul 20217:00 amRNSBlock listing Update
1st Jul 20216:16 pmRNSTotal Voting Rights
1st Jun 20213:49 pmRNSStandard form for notification of major holdings
1st Jun 20217:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.